What are the recommended testing guidelines for trichomoniasis in men?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Testing Guidelines for Trichomoniasis in Men

Men should be tested for trichomoniasis using nucleic acid amplification tests (NAATs) on urine specimens or urethral swabs, with testing recommended for symptomatic men and those in high-prevalence settings, though routine screening of asymptomatic men is not currently recommended. 1

Who to Test

Symptomatic Men

  • Test any man presenting with urethritis symptoms (dysuria, urethral discharge, penile irritation)
  • Most men with trichomoniasis are asymptomatic, but symptomatic cases warrant immediate testing 1

High-Risk Asymptomatic Men

Consider testing in:

  • Sexual partners of women diagnosed with trichomoniasis (high transmission rates support this) 1
  • Men attending STI clinics
  • Men with HIV infection
  • Men in correctional facilities
  • Men with multiple sexual partners

Important caveat: Unlike women, there is no formal recommendation for routine screening of asymptomatic men in the general population, even though men serve as important reservoirs for transmission 1.

Diagnostic Testing Methods

Preferred: NAATs (Most Sensitive)

  • Urine specimens: Sensitivity 97.2-100% 2, 3
  • Urethral/meatal swabs: Sensitivity 100% 2
  • NAATs are significantly more sensitive than traditional methods and should be the first-line diagnostic approach

Alternative: Point-of-Care Tests

The GeneXpert TV test is the only POC test validated for men:

  • Sensitivity 97.2% for male urine 3
  • Results in <1 hour
  • Requires small platform (moderately complex test)
  • Useful when immediate diagnosis and treatment are priorities

Not Recommended for Men

  • Wet mount microscopy (insensitive, requires immediate examination)
  • Culture (not readily available, less sensitive than NAATs)
  • Antigen tests (limited validation in men; primarily studied in women) 4

Specimen Collection

First-void urine is the preferred non-invasive specimen for men:

  • Collect first 20-30 mL of urine stream
  • No urethral swab needed in most cases
  • Urethral swabs can be used but are more invasive with similar sensitivity 2

For men who engage in receptive anal intercourse:

  • Consider rectal swab testing if available (though most NAATs are not FDA-cleared for rectal specimens) 5

Testing Algorithm

  1. Symptomatic men: Test immediately with NAAT on urine
  2. Partners of infected women: Test with NAAT on urine (consider expedited partner treatment while awaiting results) 1
  3. High-risk asymptomatic men in STI clinics: Consider NAAT testing on urine
  4. Test for co-infections: Always test for gonorrhea, chlamydia, HIV, and syphilis when testing for trichomoniasis 5

Follow-Up Testing

  • Test-of-cure is NOT routinely recommended for men after treatment (unlike some other STIs)
  • Rescreening at 3 months should be considered due to high reinfection rates, particularly if partner treatment is uncertain 1

Common Pitfalls

  • Don't rely on symptoms alone: Most infected men are asymptomatic but still transmit infection 1
  • Don't use wet mount in men: This is insensitive and impractical for male specimens
  • Don't forget partner notification: High transmission rates (up to 80%) mean partners need testing and treatment 1
  • Don't overlook urine cytology findings: Trichomonas may be incidentally detected on urine cytology; this warrants treatment even without formal STI testing 6

Key Differences from Women

Unlike women (who have annual screening recommendations for those <25 years or with risk factors), men have no routine screening guidelines. Testing in men is primarily symptom-driven or partner-based rather than screening-based, reflecting the current evidence gap on cost-effectiveness and feasibility of male screening programs 1.

Related Questions

As an asymptomatic male partner of a wife diagnosed with Trichomonas vaginalis, should I undergo screening before receiving treatment?
What is the recommended treatment regimen for gonorrhea and trichomoniasis?
Do men typically test negative for Trichomonas vaginalis and Gardnerella when screened?
Is there a blood test for bacterial vaginosis or trichomoniasis?
What is the recommended treatment for an asymptomatic patient with Trichomonas vaginalis detected on urine?
In a 60-year-old male with longstanding bipolar disorder who is currently taking valproic acid 500 mg twice daily, risperidone 1 mg twice daily, and zolpidem 5 mg at bedtime, and now presents with insomnia, impulsivity, and multiple falls suggestive of an impending manic episode, what is the best psychotropic medication to add?
What is the appropriate duration of antibiotic therapy for cellulitis of the extremities?
In a 55-year-old man with low mean corpuscular hemoglobin (MCH 26 pg), low mean corpuscular hemoglobin concentration (MCHC 29.8 g/dL), elevated red‑cell distribution width (RDW 16.2 %) and normal red blood cell count, hemoglobin, and hematocrit, what is the likely diagnosis and appropriate next steps?
What is the recommended loratadine dosing for adults and children of different ages, and are dose adjustments needed for elderly patients or those with renal or hepatic impairment?
How many times per day can lorazepam 1 mg intravenous be administered?
What is the appropriate dosing and management plan for wellbutrin XL (bupropion) 300 mg in an adult female with depression and ADHD?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.